138 related articles for article (PubMed ID: 27879198)
1. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
Kandela I; Chou J; Chow K;
Elife; 2015 May; 4():. PubMed ID: 27879198
[TBL] [Abstract][Full Text] [Related]
2. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
Kandela I; Chou J; Chow K; ;
Elife; 2015 May; 4():. PubMed ID: 25998055
[TBL] [Abstract][Full Text] [Related]
3. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
Mantis C; Kandela I; Aird F;
Elife; 2017 Jan; 6():. PubMed ID: 28100395
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
Peng ZH; Kopeček J
J Am Chem Soc; 2015 Jun; 137(21):6726-9. PubMed ID: 25963409
[TBL] [Abstract][Full Text] [Related]
5. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
[TBL] [Abstract][Full Text] [Related]
7. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
[TBL] [Abstract][Full Text] [Related]
8. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
[TBL] [Abstract][Full Text] [Related]
10. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
11. Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.
Vanden Heuvel JP; Bullenkamp J;
Elife; 2016 Jun; 5():. PubMed ID: 27336789
[TBL] [Abstract][Full Text] [Related]
12. Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations.
Chroscinski D; Sampey D; Hewitt A;
Elife; 2014 Dec; 3():. PubMed ID: 25490935
[TBL] [Abstract][Full Text] [Related]
13. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Khan I; Kerwin J; Owen K; Griner E; ;
Elife; 2015 Sep; 4():. PubMed ID: 26335297
[TBL] [Abstract][Full Text] [Related]
14. Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data.
Kandela I; Zervantonakis I; ;
Elife; 2015 May; 4():e06847. PubMed ID: 25939392
[TBL] [Abstract][Full Text] [Related]
15. Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
Sha H; Zou Z; Xin K; Bian X; Cai X; Lu W; Chen J; Chen G; Huang L; Blair AM; Cao P; Liu B
J Control Release; 2015 Feb; 200():188-200. PubMed ID: 25553823
[TBL] [Abstract][Full Text] [Related]
16. Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Blum D; LaBarge S;
Elife; 2014 Dec; 3():. PubMed ID: 25490933
[TBL] [Abstract][Full Text] [Related]
17. Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Li J; Lam M;
Elife; 2015 Jul; 4():e06434. PubMed ID: 26231042
[TBL] [Abstract][Full Text] [Related]
18. Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.
Fiering S; Ang LH; Lacoste J; Smith TD; Griner E;
Elife; 2015 Jul; 4():e04796. PubMed ID: 26179155
[TBL] [Abstract][Full Text] [Related]
19. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Bhargava A; Pelech S; Woodard B; Kerwin J; Maherali N; ;
Elife; 2016 Feb; 5():. PubMed ID: 26882073
[TBL] [Abstract][Full Text] [Related]
20. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
